Cambridge Financial Group, Inc. Illumina, Inc. Transaction History

Cambridge Financial Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$347.28 - $421.83 $6.05 Million - $7.35 Million	-17,420 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$405.61 - $524.84 $360,992 - $467,107	-890 Reduced 4.86%	17,420 $7.07 Billion
Q2 2021 Aug 13, 2021	SELL	$372.84 - $481.5 $63,382 - $81,855	-170 Reduced 0.92%	18,310 $8.66 Billion
Q1 2021 May 07, 2021	BUY	$361.28 - $504.76 $46,966 - $65,618	130 Added 0.71%	18,480 $7.1 Billion
Q4 2020 Feb 01, 2021	BUY	$292.7 - $370.96 $466,856 - $591,681	1,595 Added 9.52%	18,350 $6.79 Billion
Q3 2020 Nov 12, 2020	SELL	$268.51 - $400.74 $429,616 - $641,184	-1,600 Reduced 8.72%	16,755 $5.18 Billion
Q2 2020 Aug 14, 2020	SELL	$256.46 - $373.01 $64,114 - $93,252	-250 Reduced 1.34%	18,355 $6.8 Billion
Q1 2020 May 11, 2020	BUY	$209.2 - $335.53 $158,992 - $255,002	760 Added 4.26%	18,605 $5.08 Billion
Q4 2019 Feb 12, 2020	BUY	$288.29 - $335.49 $330,092 - $384,136	1,145 Added 6.86%	17,845 $5.92 Billion
Q3 2019 Nov 12, 2019	SELL	$266.84 - $378.23 $472,306 - $669,467	-1,770 Reduced 9.58%	16,700 $5.08 Billion
Q2 2019 Jul 29, 2019	BUY	$300.59 - $368.15 $33,064 - $40,496	110 Added 0.6%	18,470 $6.8 Billion
Q1 2019 May 03, 2019	BUY	$272.57 - $321.18 $1.17 Million - $1.38 Million	4,310 Added 30.68%	18,360 $5.7 Billion
Q4 2018 Feb 01, 2019	BUY	$272.46 - $366.54 $3.83 Million - $5.15 Million	14,050 New	14,050 $4.21 Billion

899

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Cambridge Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Cambridge Financial Group, Inc. with notifications on news.